Abstract:Purpose Antifungal resistance associated with the extensive use of antifungals and biofilm formation presents major clinical challenges. Thus, new therapeutic strategies for fungal infections are urgently required. This study aimed to evaluate the in vitro antifungal effects of the natural bioactive alkaloid berberine against Candida spp. in planktonic and biofilm conditions. Methods Using the CLSI M27-A3 reference method for broth dilution antifungal susceptibility testing of yeasts, the MICs for five standard strains comprised of Candida albicans (ATCC 10231, ATCC 90028), Candida krusei (ATCC 6258), Candida glabrata (ATCC 90030), Candida dubliniensis (MYA 646), and six clinical isolates (CLC1–CLC6) were tested. The 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assay was used to evaluate the inhibitory effects of berberine against Candida biofilms. The optical density value at 490 nm was measured and illustrated using concentration-absorbance curves. Finally, the effects were quantified by confocal laser scanning microscopy (CLSM), and 3-dimensional reconstruction was performed. The viability inhibition rates, biofilm formation, and thickness decrease rates were tested and analyzed using independent-samples t-test. The differences among the five Candida strains were analyzed using one way ANOVA. Results The MICs for the five standard strains described above were 80, 160, 10, 20, and 40 μg/mL, respectively, which was similar to that of the clinical isolates, suggesting the stable, broad-spectrum antifungal activity of berberine. Berberine exerted concentration-dependent inhibitory effects against Candida biofilms, which were enhanced with the maturation of Candida biofilms. Berberine decreased the viability of Candida biofilms, with inhibition rates by CLSM ranging from 19.89 ± 0.57% to 96.93 ± 1.37%. Following 3-dimensional reconstruction, the biofilms of the berberine-treated group displayed a poorly developed architecture, and the biofilm thickness decrease rates ranged from 15.49 ± 8.45% to 30.30 ± 15.48%. Conclusion Berberine exhibited significant antifungal activity in Candida spp. The results provide a useful reference for multiple Candida infections and biofilm infections associated with antifungal resistance. Therefore, berberine might have novel therapeutic potential as an antifungal agent or a major active component of antifungal drugs.

Study on Antifungal Activities of Hydrochloric Berberine Against Oral Candida and the Inhibitory Effects on Growth of Human Tonge Carcinoma Cells Tca8113 in Vitro

Inhibitory Effect of Berberine Α-Hydroxy Β-Decanoylethyl Sulfonate on MDA-MB-231 Cells in Vivo and in Vitro

Comparative Evaluation of ATB FUNGUS 3 Procedure and CLSI M27-A2 Broth Microdilution Method for Antifungal Susceptibility Testing of Pathogenic Yeasts

Inhibition of berberine hydrochloride on Candida albicans biofilm formation

Inhibitory effect of berberine hydrochloride against Candida albicans and the role of the HOG-MAPK pathway

In Vitro Antifungal Effects of Berberine Against Candida Spp. in Planktonic and Biofilm Conditions

[Effects of Berbamine on K562 Cells and Its Mechanisms in Vitro and in Vivo].

Berbamine Induces Fas-Mediated Apoptosis in Human Hepatocellular Carcinoma Hepg2 Cells and Inhibits Its Tumor Growth in Nude Mice

Anti-fungal Effect of Berberine on Candida Albicans by Microcalorimetry with Correspondence Analysis

[Antifugal susceptibility testing and antifugal traditional Chinese medicines screening of oral Candida isolated from head and neck cancer patients treated with radiotherapy or chemotherapy]

Susceptibility Test by Berberine Hydrochloride Combined with Antifungal Agents Against Trichophyton Rubrum in Vitro

Effects of Berberine on the Proliferation of Human Pulmonary Carcinoma Cells

Experimental Study of Berberine on Diabetes Mellitus Complicated with Systemically Candida Albicans Infection

The Antifungal Effects of Berberine and Its Proposed Mechanism of Action Through CYP51 Inhibition, as Predicted by Molecular Docking and Binding Analysis

Studies on the Effects of Berbamine on the Human Leukemia Cell Line Nb4.

Studies on the antifungal effects of Hinokitiol on Candida albicans: inhibition of germ tube formation and synergistic pharmacological effects of miconazole

Berbamine Induces Apoptosis in Human Hepatoma Cell Line SMMC7721 by Loss in Mitochondrial Transmembrane Potential and Caspase Activation

Cnsc-02. Anticancer Ability Of The Berberine To Promote The Apoptosis Effect And Attenuate The Ros Generation Capacity On Dbtrg Brain Cancer Cells

[Inhibitory effect and mechanism of sodium cantharidate on human tongue squamous cell carcinoma CAL27 cells]

Scene Change Detection Using Shape Information in MPEG-4 Compressed Domain

Molecular Mechanisms of Action of Herbal Antifungal Alkaloid Berberine, in Candida albicans